Cargando…
Big Data Offers Novel Insights for Oncolytic Virus Immunotherapy
Large-scale assays, such as microarrays, next-generation sequencing and various “omics” technologies, have explored multiple aspects of the immune response following virus infection, often from a public health perspective. Yet a lack of similar data exists for monitoring immune engagement during onc...
Autores principales: | Swift, Stephanie L., Stojdl, David F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776200/ https://www.ncbi.nlm.nih.gov/pubmed/26861383 http://dx.doi.org/10.3390/v8020045 |
Ejemplares similares
-
High-throughput screening to enhance oncolytic virus immunotherapy
por: Allan, KJ, et al.
Publicado: (2016) -
Deletion of immunomodulatory genes as a novel approach to oncolytic vaccinia virus development
por: Ho, Tiffany Y., et al.
Publicado: (2021) -
Fusogenic Viruses in Oncolytic Immunotherapy
por: Krabbe, Teresa, et al.
Publicado: (2018) -
Oncolytic viruses for cancer immunotherapy
por: Hemminki, Otto, et al.
Publicado: (2020) -
Measles Virus as an Oncolytic Immunotherapy
por: Engeland, Christine E., et al.
Publicado: (2021)